Eli Lilly and Cipla enter into a strategic partnership in India to enhance access to Lilly’s key diabetes products Kumar Jeetendra | October 4, 2021 Mumbai, Oct 04 2021: Eli Lilly and Company (India) Pvt. Ltd. (hereinafter referred as “Lilly”), headquartered in Gurgaon, is a wholly owned subsidiary of Eli Lilly and Company, a global biopharmaceutical company headquartered in Indianapolis, USA, and Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced its strategic partnership in …
Glenmark receives USFDA approval to market generic anti-biotic cream Kumar Jeetendra | September 22, 2021 Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market Clindamycin Phosphate Foam, an antibiotic used for treating bacterial infections, in the American market. The Mumbai-based firm has received final approval from the US Food and Drug Administration (USFDA) to market Clindamycin Phosphate Foam (1 per cent) which is …
Dr Reddy’s gets DCGI gesture to lead stage 3 trial of Sputnik Light in India Kumar Jeetendra | September 15, 2021 Dr Reddy’s Laboratories was granted approval by the drugs regulator to conduct Phase III trials of single-dose COVID-19 vaccination Sputnik Light. According to Hindustan Times, the subject expert committee (SEC), of the Central Drugs Standard Control Organisation CDSO (CDSO), had recommended to the Drugs Controller General of India(DCGI) that approval be granted to conduct Bridging …
Aleor Dermaceuticals gets USFDA gesture for generic antibacterial gel Kumar Jeetendra | September 13, 2021 Drug firm Alembic Pharmaceuticals on Monday said its joint venture Aleor Dermaceuticals has received approval from the US health regulator for generic Metronidazole gel, used in the treatment of inflammatory lesions of rosacea. Aleor Dermaceuticals Ltd has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) …
Granules India And Jubilant Cadista Recall Products In US Market Kumar Jeetendra | September 13, 2021 Granules India and Jubilant Cadista, two generic drug manufacturers, are recalling several goods in the United States, the world’s largest market for medicines, for various reasons. According to the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), Granules India’s US-based unit is recalling over 1.14 crore Naproxen Sodium tablets, a non-steroidal …
Aurobindo Pharma gets USFDA gesture for malignancy treatment injection Kumar Jeetendra | August 27, 2021 New Delhi, Aug 27 (PTI) Drug firm Aurobindo Pharma on Friday said its arm Eugia Pharma Specialities has received approval from the US health regulator for Cyclophosphamide injection, used in the treatment of several types of cancer. The company”s subsidiary “Eugia Pharma Specialities Ltd has received a 505(b)(2) NDA approval from the US Food & …
Cipla and Kemwell Biopharma announce execution of a joint venture agreement for developing, manufacturing and commercialising biosimilars Kumar Jeetendra | August 25, 2021 Mumbai, India, August 25, 2021: Cipla Limited (BSE: 500087 | NSE: CIPLA EQ, hereafter referred to as “Cipla”), a leading global pharmaceutical company and Kemwell Biopharma Private Limited, a leading biopharmaceutical Contract Development and Manufacturing Organisation (CDMO), announced execution of a joint venture agreement to develop, manufacture and commercialise biosimilars for global markets. For this …
Pfizer,AstraZeneca COVID-19 vaccines less viable against Delta variation: Oxford-drove study Kumar Jeetendra | August 19, 2021 The COVID-19 vaccines by Pfizer and AstraZeneca are less effective against the Delta variant of coronavirus compared to the Alpha variant, according to a study led by researchers at the University of Oxford.The researchers, however, noted that with Delta, Pfizer-BioNTech vaccine and Oxford-AstraZeneca preventive, known as Covishield in India, still offer good protection against new …
Pfizer submits information for third dose endorsement in US Kumar Jeetendra | August 17, 2021 Pfizer and BioNTech on Monday submitted preliminary clinical data to US health authorities as part of their effort to seek authorization for a third dose of their Covid-19 vaccine for all Americans. Last week, the United States approved the booster shot of Pfizer-BioNTech and Moderna vaccines for people with weakened immune systems. Pfizer and BioNTech …
Wockhardt inks agreement to deliver, supply Sputnik vaccine to Dubai-based firm Kumar Jeetendra | August 13, 2021 Drug maker Wockhardt on Friday said it has inked a pact with Dubai-based Enso Healthcare and a subsidiary of Russian Direct Investment Fund (RDIF) for production and supply of COVID-19 vaccine Sputnik. The Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF …
Cipla receives final approval for generic version of Durezol® Kumar Jeetendra | August 12, 2021 Mumbai, India; August 12, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the United States Food and Drug Administration (US FDA). Cipla’s Difluprednate Ophthalmic Emulsion 0.05% is AB-rated …
Provided more than 1 billion COVID-19 vaccine dose up until now: BioNTech Kumar Jeetendra | August 9, 2021 BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca, the German biotech group said on Monday. The supply tally, up from more than 700 million doses announced by the biotech firm in June, compares with AstraZeneca saying …
